EBRD boosts investment in Greek pharma industry
Photo: EBRD
The European Bank for Reconstruction and Development (EBRD) is increasing its equity investment in Greek pharmaceutical firm Famar, committing an additional 5.2 million euros to support the company’s expansion in Greece and its first production facility in Germany.
Access to paid information is limited
If You already have a account, please log in
Subscription to paid content
Gain access to all that Trend has to offer, as well as to premium, licensed content via subscription or direct purchase through a credit card.
